Navigation Links
Response time to open arteries for most critical patients still too slow
Date:11/16/2011

most of the damage has been done so UTHealth researchers have been concentrating on how to shorten that time to two hours or less.

The only way to lower the current time from symptoms to opening the artery is to treat the patient in the ambulance, McCarthy said. A year ago he presented results of a UTHealth clinical trial called Pre-Hospital Administration of Thrombolytic Therapy with Urgent Culprit Artery Revascularization (PATCAR). That trial showed that the mortality rate of patients arriving via EMS could be lowered to 2.9 percent by giving them a low dose of a clot-busting drug intravenously before they arrived at the hospital. The research was a collaboration of UTHealth, Memorial Hermann Heart & Vascular Institute-Texas Medical Center (HVI) and the Houston Fire Department.

"We know we've optimized the hospital system and integrated that with EMS but for the cohort that calls 911, that's still not enough," he said. "We need to figure out something else." The researchers are seeking additional funding to expand PATCAR to more patients.

The researchers looked at 37,715 patients in the American College of Cardiology's National Cardiovascular Data Registry. The presentation title is "EMS Transport of STEMI Patients Shortens Ischemic Times and is Associated with a Higher Risk Population: Results from the ACTION Registry."


'/>"/>

Contact: Deborah Mann Lake
deborah.m.lake@uth.tmc.edu
University of Texas Health Science Center at Houston
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Increasing dosage of clopidogrel for patients with genetic variation improves response to medication
2. Study identifies factors linked with better medication response for treatment of juvenile arthritis
3. Gladstone scientists identify gene critical for cell responses to oxygen deprivation
4. MVA-B Spanish HIV vaccine shows 90 percent immune response in humans
5. Chemo plus radiation before surgery increases tumor response for rectal cancer
6. Decoding vaccination: Mayo researchers reveal genetic underpinnings of response to measles vaccine
7. Childhood maltreatment linked to long-term depression risk and poor response to treatment
8. Fatty Comfort Foods May Alter Brains Response to Sadness
9. Signaling molecule identified as essential for maintaining a balanced immune response
10. Low Empathy Response in Brain Might Point to Autism Gene
11. Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... NY (PRWEB) , ... August 04, 2015 , ... ... vegetarian capsule formula. Healthy Origins® Cognizin® is a trademark for Citicoline, a ... base for a capsule for those applications which have more of a semi-solid ...
(Date:8/4/2015)... ... August 04, 2015 , ... An article published July 27th by ... viable method for encouraging people to lose weight. Specifically the study compared control patients ... loss success, adding a financial incentive to the overall incentive of increased health. According ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... commercial customers. Finding reliable hardware can be difficult and troublesome for companies. ... an office together or designing a new facility, it is imperative to include ...
(Date:8/4/2015)... ... August 04, 2015 , ... Bayco Products, Inc. announces a new industrial-grade LED ... on hard hats that have a flip-up face shield. The sleek contours of the ... without having to remove their headlamp when raising or lowering their face shield or ...
(Date:8/4/2015)... ... , ... Angelina Jolie is in it at age 39. “It” is menopause, ... Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s leading ... menopause. , Myth #1: Menopause only affects old ladies. – Menopause can affect ...
Breaking Medicine News(10 mins):Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3
... Bad Reactions to FDA Safety,Program, WASHINGTON, April 2, 2008 ... Americans who have ever taken a,prescription drug experienced a side ... but the majority of consumers don,t know they can,report these ... safety problems., To help make the public aware of ...
... 2, 2008) Dr. Richard Stein, a professor emeritus ... Dentistry, has been named the 2007 recipient of the ... prize is presented annually to the top ranked spinal ... Research,s (CIHR) investigator-initiated grants competition. , Stein ...
... WEDNESDAY, April 2 (HealthDay News) -- Two well-known HIV ... of heart attacks, European researchers reported Wednesday. , Based ... is now conducting a safety review of the potential ... take a combination of antiretroviral drugs, which include a ...
... GXDX ) today announced that the company,s 2008 annual meeting,of ... June 17, 2008 at,the company,s headquarters in Carlsbad, CA., ... business on,April 25, 2008 as the record date for the ... to vote at, the annual meeting., About Genoptix, Inc., ...
... ORLANDO, Fla., April 2, 2008 The American,Red ... assistance and,other benefits to Hurricane Katrina and Rita ... Louisiana and south Mississippi. These,funds, initially set aside ... are being used to bolster existing individual,assistance through ...
... YORK, April 2, 2008 Easter Seals is shining ... among the,vast array of services the national nonprofit provides ... the last 20 years, Easter Seals has seen a ... autism the organization serves.,Today, as many as one in ...
Cached Medicine News:Health News:Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects 2Health News:Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects 3Health News:Alberta physiologist earns top national honor for spinal cord research 2Health News:HIV Drugs Linked to Increased Risk of Heart Attack 2Health News:HIV Drugs Linked to Increased Risk of Heart Attack 3Health News:In Face of Continuing Katrina and Rita Needs Red Cross Adds Resources to Gulf Coast 2Health News:In Face of Continuing Katrina and Rita Needs Red Cross Adds Resources to Gulf Coast 3Health News:Easter Seals Celebrates World Autism Awareness Day With Campaign to Highlight Nationwide Services Available to Families Living With Autism Today 2
(Date:8/4/2015)... 2015 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... and Chief Executive Officer, Doug Godshall , is ... Growth Conference at 8:30 a.m. EDT on Thursday, August ... 2015 at the InterContinental Boston. A live ...
(Date:8/4/2015)... Research and Markets ... the "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" report to ... 2020 - Focus on Patient Comfort and Operational ... the market, competitive landscape, and trends for three ...
(Date:8/4/2015)... 2015  Dr. Keesha Ewers of ... approval of flibanserin, or what is being touted ... of decreased female sexual desire back several decades. ... and addressing libido as a singular symptom with ... Photo - ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5
... Vical Incorporated,(Nasdaq: VICL ) today announced ... independently produced video report featuring metastatic,melanoma patients treated ... is expected to be used,broadly by stations in ... Allovectin-7(R) trial, and in other cities by stations ...
... III Results Demonstrate Superior Reduction in In-Segment Late Loss, Non-Inferiority in ... ... V Compared to TAXUS, ABBOTT PARK, Ill., April ... Association (JAMA) demonstrated,that use of Abbott,s XIENCE(TM) V Everolimus Eluting Coronary ...
Cached Medicine Technology:Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 2Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 3Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 4Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 5Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5
For the quantitative in vitro determination of Transferrin in human serum...
For the quantitative in vitro determination of Transferrin in Serum...
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Medicine Products: